
What is it?
A booster to transform groundbreaking ideas in the field of target identification, disease knowledge and translational science into innovative therapeutic solutions. We partner with best-in-class academics to serve a common goal: accelerating innovation for patients.
About the program
- A seed funding of 120 000 euros.
- A dedicated support of a Sanofi scientific expert.
- A steppingstone to further collaboration.
Who are we looking for?
Principal investigators from academic partner institutions developing cutting-edge therapeutic solutions in the following areas:
- Oncology
- Immunology and inflammatory diseases
- Rare and Neurological diseases
- Cell and gene therapies
- Vaccines
Ongoing call for projects
Submission deadline June 2nd, 2023
Only principal investigators belonging to one of the iAwards partner institutions are eligible to this call. For more information, please contact EMEA_iAwards-Europe@sanofi.com.
Our selection process
A fast process to select and start projects in less than 8 months
Week 0
Call launch
2022 iAwards Recipients
ADJALI Oumeya
Inserm
AL JAMAL Khuloud
King’s College London
BAEZA-GARCIA Alvaro
Inserm
BOCKELMANN Ulrich
Inserm
CHAIGNE Benjamin
AP-HP
CORGNAC Stephanie
Gustave Roussy
EDBAUER Dieter
Ludwig Maximilian University of Munich
FILLATREAU Simon
Inserm
GERST Jeffrey
The Weizmann Institute
GLOWACKI François
Inserm
MAGNON Claire
Inserm
SAUZEAU Vincent
Inserm
SHACHAR Idit
The Weizmann Institute
SKIDMORE John
University of Cambridge
ULITSKY Igor
The Weizmann Institute
VLLASALIU Driton
King’s College London
WOSZCZEK Grzegorz
King’s College London
iAward Program Partners
France
Assistance Publique – Hôpitaux de Paris
AP-HP
Centre Léon Bérard
CLB
Centre International de Recherche en Infectiologie
CIRI
Gustave Roussy
INSERM
Institut National de la Santé Et de la Recherche Médicale
Institut Curie
Institut de la Vision
Institut Imagine
Institut Pasteur
Israel
Weizmann Institute
Spain
Spanish National Cancer Research Centre
CNIO
Germany
Berlin Institute of Health at La Charité
BIH-Charité
German Cancer Research Center
DKFZ
Ludwig Maximilians Universität München
LMU
Max Delbrück Center
MDC
Translational Oncology
TrOn
United Kingdom
Cambridge University
King’s College London
Holland
The Netherlands Cancer Institute
Switzerland
Université de Genève
For more information
contact EMEA_iAwards-Europe@sanofi.com